Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Brainxell Inc Terminally differentiated human cortical glutamatergic neurons; Derived from iPSC line WC-30, male. No known neurological or psychiatric disorders. Contents: 1 vial of ≥1x10^6 viable cryopreserved cells
SDP

Supplier:  Brainxell Inc BX0300301M

Encompass_Preferred

Marker Expression: Cortical Glutamatergic Neurons (BX-0300) have high neuronal purity (>80%) and comprise predominantly excitatory neurons. Labeling with the pan-neuronal marker MAP2 (red) highlights the neuronal purity of these cells. Labeling with the glutamatergic-specific marker FOXP2 indicates the overwhelming presence of glutamatergic neurons. Function: Cortical Glutamatergic Neurons exhibit pronounced electrophysiological activity after two weeks in culture, as demonstrated by multi-electrode array (MEA) recordings. Related diseases: Alzheimer’s & Huntington’s Disease. Primary neurotransmitter released: Glutamate

Catalog No. NC2216415


May include imposed supplier surcharges.
Only null left
Add to Cart
This item is not returnable. View return policy

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.